Find trials
Search tips

A Study to Evaluate PancreaSeq® for Assessing Pancreatic Cystic Lesions

Overview

About this study

The purpose of this study is to evaluate the validity and accuracy of the PancreaSeq assay on long-term outcomes of pancreatic cystic lesions (PCL).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients ≥ 18 years.
  • All prospective and retrospective patients that have cyst fluid sent for PancreaSeq analysis.

Exclusion Criteria: 

  • Sample not sufficient for analysis.
  • Age < 18 years.
  • Pregnancy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Wallace, M.D.

Closed for enrollment

Contact information:

Stacey Pecenka BAS, M.P.H.

(904) 953-4261

Pecenka.Stacey@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20507147

Mayo Clinic Footer